BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25105894)

  • 1. The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.
    Harvey RM; Hughes CE; Paton AW; Trappetti C; Tweten RK; Paton JC
    PLoS One; 2014; 9(8):e103625. PubMed ID: 25105894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood.
    Harvey RM; Ogunniyi AD; Chen AY; Paton JC
    Infect Immun; 2011 Oct; 79(10):4122-30. PubMed ID: 21788389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.
    Bewley MA; Naughton M; Preston J; Mitchell A; Holmes A; Marriott HM; Read RC; Mitchell TJ; Whyte MK; Dockrell DH
    mBio; 2014 Oct; 5(5):e01710-14. PubMed ID: 25293758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
    Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
    Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
    Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
    mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumolysin Induces 12-Lipoxygenase-Dependent Neutrophil Migration during
    Adams W; Bhowmick R; Bou Ghanem EN; Wade K; Shchepetov M; Weiser JN; McCormick BA; Tweten RK; Leong JM
    J Immunol; 2020 Jan; 204(1):101-111. PubMed ID: 31776202
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A.
    Song M; Teng Z; Li M; Niu X; Wang J; Deng X
    J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.
    Price KE; Camilli A
    J Bacteriol; 2009 Apr; 191(7):2163-8. PubMed ID: 19168620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumolysin-Dependent Calpain Activation and Interleukin-1α Secretion in Macrophages Infected with Streptococcus pneumoniae.
    Fang R; Wu R; Du H; Jin M; Liu Y; Lei G; Jiang B; Lei Z; Peng Y; Nie K; Tsuchiya K
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally-occurring serotype 3 Streptococcus pneumoniae strains that lack functional pneumolysin and autolysin have attenuated virulence but induce localized protective immune responses.
    Wong ΗE; Tourlomousis P; Paterson GK; Webster S; Bryant CE
    PLoS One; 2023; 18(3):e0282843. PubMed ID: 36897919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
    Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
    BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.
    Badgujar DC; Anil A; Green AE; Surve MV; Madhavan S; Beckett A; Prior IA; Godsora BK; Patil SB; More PK; Sarkar SG; Mitchell A; Banerjee R; Phale PS; Mitchell TJ; Neill DR; Bhaumik P; Banerjee A
    PLoS Pathog; 2020 Nov; 16(11):e1009016. PubMed ID: 33216805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
    Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
    J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae.
    Periselneris J; Turner CT; Ercoli G; Szylar G; Weight CM; Thurston T; Whelan M; Tomlinson G; Noursadeghi M; Brown J
    Immunology; 2022 Nov; 167(3):413-427. PubMed ID: 35835695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells.
    Taylor SD; Sanders ME; Tullos NA; Stray SJ; Norcross EW; McDaniel LS; Marquart ME
    PLoS One; 2013; 8(4):e61300. PubMed ID: 23577214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.
    McNeela EA; Burke A; Neill DR; Baxter C; Fernandes VE; Ferreira D; Smeaton S; El-Rachkidy R; McLoughlin RM; Mori A; Moran B; Fitzgerald KA; Tschopp J; Pétrilli V; Andrew PW; Kadioglu A; Lavelle EC
    PLoS Pathog; 2010 Nov; 6(11):e1001191. PubMed ID: 21085613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear.
    Schachern PA; Tsuprun V; Goetz S; Cureoglu S; Juhn SK; Briles DE; Paparella MM; Ferrieri P
    JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):937-43. PubMed ID: 24051749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.
    Thanawastien A; Joyce KE; Cartee RT; Haines LA; Pelton SI; Tweten RK; Killeen KP
    Vaccine; 2021 Mar; 39(11):1652-1660. PubMed ID: 32532546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.
    Berry AM; Paton JC
    Infect Immun; 2000 Jan; 68(1):133-40. PubMed ID: 10603379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
    Dessing MC; Florquin S; Paton JC; van der Poll T
    Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.